These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 10442421

  • 21. In-vitro activity of trovafloxacin against sensitive and resistant aerobic bacteria using the standard microdilution broth method and Etest.
    Dembry LM, Farrel PA, Orcutt DR, Gerrity LA, Andriole VT.
    J Antimicrob Chemother; 1997 Jun; 39 Suppl B():35-42. PubMed ID: 9222068
    [Abstract] [Full Text] [Related]

  • 22. The activity of the methylpiperazinyl fluoroquinolone CG 5501: a comparison with other fluoroquinolones.
    Wise R, Brenwald NP, Andrews JM, Boswell F.
    J Antimicrob Chemother; 1997 Apr; 39(4):447-52. PubMed ID: 9145816
    [Abstract] [Full Text] [Related]

  • 23. In vitro activity of gatifloxacin alone and in combination with cefepime, meropenem, piperacillin and gentamicin against multidrug-resistant organisms.
    Dawis MA, Isenberg HD, France KA, Jenkins SG.
    J Antimicrob Chemother; 2003 May; 51(5):1203-11. PubMed ID: 12697632
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. In vitro activity of eight fluoroquinolones against multiresistant Stenotrophomonas maltophilia.
    Sánchez-Hernández J, Manzanares MA, Gutiérrez Zufiaurre MN, Muñoz Criado S, Muñoz Bellido JL, García-Rodríguez JA.
    Rev Esp Quimioter; 1999 Sep; 12(3):234-6. PubMed ID: 10878514
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Resistance of Stenotrophomonas maltophilia to Fluoroquinolones: Prevalence in a University Hospital and Possible Mechanisms.
    Jia W, Wang J, Xu H, Li G.
    Int J Environ Res Public Health; 2015 May 13; 12(5):5177-95. PubMed ID: 25985315
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. In vitro antimicrobial activity of gatifloxacin compared with other quinolones against clinical isolates from cancer patients.
    Rolston KV, Vaziri I, Frisbee-Hume S, Streeter H, LeBlanc B.
    Chemotherapy; 2004 Nov 13; 50(5):214-20. PubMed ID: 15523180
    [Abstract] [Full Text] [Related]

  • 31. Susceptibility of Xanthomonas maltophilia and amikacin-resistant gram-negative bacteria to newer antimicrobials.
    Matsuyama JR, Beail B, Wallis C, Zeleznik D, Tartaglione T.
    Clin Pharm; 1991 Jul 13; 10(7):544-8. PubMed ID: 1860303
    [Abstract] [Full Text] [Related]

  • 32. Comparison of E test and agar dilution for antimicrobial susceptibility testing of Stenotrophomonas (Xanthomonas) maltophilia.
    Yao JD, Louie M, Louie L, Goodfellow J, Simor AE.
    J Clin Microbiol; 1995 May 13; 33(5):1428-30. PubMed ID: 7615774
    [Abstract] [Full Text] [Related]

  • 33. In vitro susceptibility of 124 Xanthomonas maltophilia (Stenotrophomonas maltophilia) isolates: comparison of the agar dilution method with the E-test and two agar diffusion methods.
    Arpi M, Victor MA, Mortensen I, Gottschau A, Bruun B.
    APMIS; 1996 Feb 13; 104(2):108-14. PubMed ID: 8619912
    [Abstract] [Full Text] [Related]

  • 34. Activity of BMS284756 (T-3811) tested against anaerobic bacteria, Campylobacter jejuni, Helicobacter pylori and Legionella spp.
    Rhomberg PR, Biedenbach DJ, Jones RN.
    Diagn Microbiol Infect Dis; 2001 Feb 13; 40(1-2):45-9. PubMed ID: 11448563
    [Abstract] [Full Text] [Related]

  • 35. Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin.
    Bauernfeind A.
    J Antimicrob Chemother; 1997 Nov 13; 40(5):639-51. PubMed ID: 9421311
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Activity of Delafloxacin and Levofloxacin against Stenotrophomonas maltophilia at Simulated Plasma and Intrapulmonary pH Values.
    Vialichka A, Biagi M, Meyer K, Wu T, Shajee A, Tan X, Wenzler E.
    Microbiol Spectr; 2022 Aug 31; 10(4):e0270521. PubMed ID: 35862943
    [Abstract] [Full Text] [Related]

  • 38. Calibration of the disk diffusion test for trovafloxacin susceptibility testing of four anaerobic species.
    Kronvall G, Holst E.
    Clin Microbiol Infect; 2000 Apr 31; 6(4):195-201. PubMed ID: 11168107
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Gatifloxacin (AM-1155, CG 5501) susceptibility testing interpretive criteria and quality control guidelines for dilution and disk (5-microgram) diffusion methods. The Quality Control Study Group.
    Jones RN, Kugler KC, Erwin ME, Biedenbach DJ, Beach ML, Pfaller MA.
    Diagn Microbiol Infect Dis; 1999 Apr 31; 33(4):247-53. PubMed ID: 10212751
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.